Identification of resistance-modifying agents from Pteris vittata L. By untargeted metabolomic analysis and in silico screening
Abstract
Antibiotic resistance is becoming an urgent public health concern worldwide, which leads to the urgent need for research and development of new antibacterials or new resistance-modifying agents. Pteris vittata L., which belongs to the Pteridaceae family, is a hyperaccumulator plant growing in metalliferous soils. This harsh environment is supposed to induce the expression or the dispersion of multidrug-resistant phenotypes through the action of efflux pumps in bacterial membranes to exclude heavy metals. Previous studies showed the potential inhibition of P. vittata extracts on Stenophomonas maltophilia isolates. Therefore, to identify the active compounds in the plant, the whole metabolome of P. vittata was screened by untargeted analysis using the LC-MS-qToF system and then applied virtual docking to investigate the interaction of these compounds on an efflux pump model. Over one hundred compounds extracted from the root and leaf samples were docked on the SmeDEF protein using the Autodock Vina 4.2.6 application. As a preliminary result, we suggested nine flavonoid compounds showing the most negative binding energies with the chosen protein for further in vitro experimental confirmation.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Levofloxacin-Induced Tendon Rupture: A Case Report and Review of the Literature
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- Neuroprotective Effects of Epicatechin against Oxidative Stress-Induced Cognitive Impairment: A Systematic Review and Meta-Analysis
- Quality evaluation and in vitro interaction studies between levofloxacin 250mg and diclofenac sodium 50mg tablets
- Molecular Epidemiology of mcr-1 -Positive Polymyxin B-Resistant Escherichia coli Producing Extended-Spectrum β-Lactamase (ESBL) in a Tertiary Hospital in Shandong, China
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.